V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220020845 | 220008460 | 1.71 | 103.8 | Palliative (P) | 2018-01-18 | 2018-01-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032072 | CARBOPLATIN + PACLITAXEL |
| 220020846 | 220021565 | 1.66 | null | Palliative (P) | null | 2016-01-13 | GEMTUZUMAB OZOGAMICIN | N | null | 220032085 | DOCETAXEL |
| 220020847 | 220008464 | 1.78 | 75.6 | Curative (C) | 2016-12-04 | 2016-12-04 | Irinotecan + Modified De Gramont | N | N | 220032087 | GEMCARBO |
| 220020848 | 220008466 | 0 | null | Curative (C) | 2014-02-17 | 2016-04-22 | GEMTUZUMAB OZOGAMICIN | Y | N | 220032105 | GEMCARBO |
| 220020849 | 220008472 | 1.53 | 74.3 | Curative (C) | 2013-10-27 | 2013-10-27 | Carboplatin + Etoposide IV 3 day | 2 | null | 220032108 | CARBOPLATIN + ETOPOSIDE |
| 220020850 | 220008481 | null | 70.9 | Curative (C) | 2014-03-14 | 2014-03-14 | Irinotecan + Modified De Gramont | N | N | 220032113 | FLUDARABINE + MELPHALAN |
| 220020851 | 220017980 | 1.8 | 76.7 | Curative (C) | 2015-03-01 | 2015-03-01 | UKALL14- Maintenance | Y | N | 220032121 | METHOTREXATE |
| 220020852 | 220017981 | 1.64 | 109.499 | Curative (C) | 2015-05-18 | 2015-05-29 | FLUOROURACIL + OXALIPLATIN | 2 | null | 220032126 | FLUDARABINE + MELPHALAN |
| 220020853 | 220008494 | 1.75 | 78 | Curative (C) | 2014-12-08 | 2014-12-09 | Irinotecan + De Gramont | 2 | N | 220032156 | OXALIPLATIN + MDG |
| 220020854 | 220008501 | 1.76 | 64.3 | Curative (C) | 2015-07-10 | 2015-07-11 | Fludarabine + Melphalan RIC Allo | 99 | N | 220032158 | GEMTUZUMAB OZOGAMICIN |
| 220020855 | 220008505 | 1.57 | null | Disease modification (D) | null | 2014-04-02 | UKALL 14 TRIAL | null | null | 220032159 | OXALIPLATIN + MDG |
| 220020856 | 220017985 | 1.67 | 64.8 | Curative (C) | 2016-06-30 | 2016-09-14 | ECX | null | null | 220032164 | UKALL2014 |
| 220020858 | 220008524 | 1.68 | 75 | Curative (C) | 2015-03-13 | 2015-03-20 | Cytarabine intrathecal | N | N | 220032227 | CYTARABINE INTRATHECAL |
| 220020859 | 220008528 | 1.65 | 97.2 | Curative (C) | 2016-04-25 | 2016-04-30 | Cytarabine intrathecal | 02 | N | 220032251 | CYTARABINE INTRATHECAL |
| 220020861 | 220008540 | 1.77 | 106 | Curative (C) | 2014-01-26 | 2014-01-27 | ECX | N | N | 220032265 | FLUDARABINE + MELPHALAN |
| 220020862 | 220008544 | null | null | Curative (C) | 2013-12-31 | 2014-01-16 | UKALL14- Maintenance | N | N | 220032272 | METHOTREXATE |
| 220020863 | 220008557 | 1.75 | 85.2 | Curative (C) | 2019-05-20 | 2019-05-21 | UKALL14- Ph 1 Induction | N | N | 220032316 | IRINOTECAN + MDG |
| 220020864 | 220008561 | 1.6 | 43 | Palliative (P) | null | 2015-01-29 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220032328 | FLUDARABINE + MELPHALAN |
| 220020865 | 220008575 | 0 | 92.9 | Curative (C) | 2013-06-25 | 2014-03-04 | Carboplatin + Etoposide IV 3 day | 2 | null | 220032371 | CARBOPLATIN + ETOPOSIDE |
| 220020866 | 220014634 | null | 57 | null | 2017-11-14 | 2017-11-18 | IDARUBICIN | null | null | 220032382 | IDARUBICIN |
| 220020867 | 220014636 | null | 48.1 | Palliative (P) | 2017-01-30 | 2017-02-06 | METHOTREXATE | N | N | 220032405 | METHOTREXATE |
| 220020868 | 220008590 | 1.48 | 70.1 | Curative (C) | 2014-03-25 | 2014-05-25 | ECX | N | N | 220032418 | OXALIPLATIN + MDG |
| 220020869 | 220008600 | 1.6 | 53.1 | null | 2017-04-30 | 2017-05-14 | CARBOPLATIN + PACLITAXEL | Y | null | 220032464 | CARBOPLATIN + PACLITAXEL |
| 220020870 | 220008604 | 1.48 | 0 | Palliative (P) | 2015-09-06 | 2015-09-13 | Irinotecan + Modified De Gramont | 2 | N | 220032476 | GEMCARBO |
| 220020871 | 220008616 | 1.55 | 71 | Palliative (P) | 2016-01-31 | 2016-02-03 | Fludarabine + Melphalan RIC Allo | N | N | 220032524 | PONATINIB |
| 220020872 | 220008622 | 1.65 | 66.3 | Adjuvant (A) | 2016-04-15 | 2016-06-06 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 220032532 | PACLITAXEL |
| 220020873 | 220008634 | 1.67 | null | Disease modification (D) | 2014-10-28 | 2015-01-04 | METHOTREXATE | 02 | N | 220032602 | GEMTUZUMAB OZOGAMICIN |
| 220020874 | 220008642 | null | null | Disease modification (D) | null | 2016-07-27 | Clofarabine + Cytarabine | 02 | N | 220032610 | METHOTREXATE |
| 220020875 | 220018014 | 1.76 | 80 | Curative (C) | 2016-10-14 | 2016-10-24 | Carboplatin + Etoposide IV 3 day | N | N | 220032635 | CARBOPLATIN + ETOPOSIDE |
| 220020876 | 220008668 | 1.58 | 62.5 | Curative (C) | 2014-10-24 | 2014-12-10 | CARBOPLATIN + GEMCITABINE | N | N | 220032681 | CISPLATIN + GEMCITABINE |
| 220020878 | 220008694 | null | 85.6 | Disease modification (D) | null | 2018-02-12 | UKALL14- Ph 2 Induction | 02 | N | 220032728 | CLOFARABINE + CYTARABINE |
| 220020879 | 220008699 | 1.62 | null | Curative (C) | 2017-03-25 | 2017-08-04 | Alemtuzumab cond (RI ALLO CAMP100) | 01 | N | 220032740 | ALEMTUZUMAB |
| 220020880 | 220008701 | 1.8 | 63.1 | Curative (C) | 2014-04-27 | 2014-05-17 | Docetaxel 75mg/m2 (21 day) | null | N | 220032750 | OXALIPLATIN + MDG |
| 220020881 | 220008705 | 1.69 | 115.8 | Curative (C) | 2015-05-15 | 2015-05-18 | CARBOPLATIN + ETOPOSIDE | N | N | 220032770 | CARBOPLATIN + ETOPOSIDE |
| 220020882 | 220008708 | 1.79 | 66.8 | Curative (C) | 2014-11-04 | 2014-11-28 | Paclitaxel (2 or 3 weekly) | 2 | N | 220032778 | PACLITAXEL |
| 220020883 | 220008713 | null | 76.2 | Curative (C) | 2015-04-25 | 2016-12-26 | GEMTUZUMAB OZOGAMICIN | N | n | 220032784 | GEMTUZUMAB OZOGAMICIN |
| 220020884 | 220008716 | 1.72 | 86.9 | Curative (C) | 2015-11-12 | 2015-11-13 | PACLITAXEL | 02 | N | 220032789 | PACLITAXEL |
| 220020885 | 220008718 | 1.85 | null | Curative (C) | 2017-05-18 | 2017-08-20 | Paclitaxel 7 day | 2 | null | 220032794 | PACLITAXEL |
| 220020887 | 220008731 | null | 58.2 | Curative (C) | 2015-12-05 | 2015-12-11 | Cytarabine intrathecal | N | N | 220032856 | CYTARABINE INTRATHECAL |
| 220020888 | 220008736 | 1.62 | 63.1 | Curative (C) | 2017-07-02 | 2017-08-06 | Carboplatin + Paclitaxel (3 weekly) | null | null | 220032863 | CARBOPLATIN + PACLITAXEL |
| 220020889 | 220008743 | 1.77 | 96.5 | Palliative (P) | 2018-06-21 | 2018-06-21 | CISPLATIN + GEMCITABINE | 2 | N | 220032872 | GEMTUZUMAB OZOGAMICIN |
| 220020890 | 220014703 | 1.52 | null | Adjuvant (A) | 2018-08-02 | 2018-08-02 | CISPLATIN + GEMCITABINE | N | N | 220032908 | PONATINIB |
| 220020891 | 220008758 | 1.84 | 84.8 | Disease modification (D) | 2015-12-13 | 2015-12-28 | Docetaxel 100mg/m2 (21 day) | 2 | N | 220032911 | PONATINIB |
| 220020892 | 220019894 | 1.72 | null | Curative (C) | 2016-09-27 | 2016-09-27 | Clofarabine + Cytarabine | N | N | 220032973 | CISPLATIN + GEMCITABINE |
| 220020893 | 220008777 | null | 88.5 | Curative (C) | 2015-08-04 | 2015-09-04 | Irinotecan + Modified De Gramont | N | N | 220032991 | ECX |
| 220020895 | 220008811 | 1.8 | 87.7 | Curative (C) | 2014-04-21 | 2014-04-29 | Clofarabine + Cytarabine | N | null | 220033117 | FBC |
| 220020896 | 220008814 | 1.83 | 68 | Curative (C) | 2016-09-22 | 2016-10-03 | Alemtuzumab | N | N | 220033122 | ALEMTUZUMAB |
| 220020897 | 220019900 | null | 97 | Palliative (P) | 2018-07-29 | 2018-07-29 | CARBOPLATIN + PACLITAXEL | N | N | 220033134 | CARBOPLATIN + PACLITAXEL |
| 220020898 | 220008827 | null | 66.3 | Disease modification (D) | 2017-11-26 | 2017-11-30 | Mitox + Tretinoin Spanish Course 3 | Y | N | 220033156 | MITOXANTRONE |
| 220020900 | 220008838 | 1.68 | 86.1 | Curative (C) | 2013-12-26 | 2014-02-05 | CARBOPLATIN + ETOPOSIDE | 02 | N | 220033231 | CARBOPLATIN + ETOPOSIDE |